PharmaCyte Biotech Stock Forecast - Relative Strength Index
| PMCB Stock | USD 0.98 0.04 4.79% |
PharmaCyte Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast PharmaCyte Biotech stock prices and determine the direction of PharmaCyte Biotech's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of PharmaCyte Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The RSI of PharmaCyte Biotech's share price is at 55 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling PharmaCyte Biotech, making its price go up or down. Momentum 55
Impartial
Oversold | Overbought |
Using PharmaCyte Biotech hype-based prediction, you can estimate the value of PharmaCyte Biotech from the perspective of PharmaCyte Biotech response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards PharmaCyte Biotech using PharmaCyte Biotech's stock options and short interest. It helps to benchmark the overall future attitude of investors towards PharmaCyte using crowd psychology based on the activity and movement of PharmaCyte Biotech's stock price.
PharmaCyte Biotech Implied Volatility | 0.6 |
PharmaCyte Biotech's implied volatility exposes the market's sentiment of PharmaCyte Biotech stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if PharmaCyte Biotech's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that PharmaCyte Biotech stock will not fluctuate a lot when PharmaCyte Biotech's options are near their expiration.
PharmaCyte Biotech after-hype prediction price | USD 1.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PharmaCyte | Build AI portfolio with PharmaCyte Stock |
Prediction based on Rule 16 of the current PharmaCyte contract
Based on the Rule 16, the options market is currently suggesting that PharmaCyte Biotech will have an average daily up or down price movement of about 0.0375% per day over the life of the 2026-04-17 option contract. With PharmaCyte Biotech trading at USD 0.98500001, that is roughly USD 3.69E-4 . If you think that the market is fully incorporating PharmaCyte Biotech's daily price movement you should consider acquiring PharmaCyte Biotech options at the current volatility level of 0.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 PharmaCyte Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast PharmaCyte Biotech's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in PharmaCyte Biotech's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for PharmaCyte Biotech stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current PharmaCyte Biotech's open interest, investors have to compare it to PharmaCyte Biotech's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of PharmaCyte Biotech is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in PharmaCyte. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
PharmaCyte Biotech Additional Predictive Modules
Most predictive techniques to examine PharmaCyte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PharmaCyte using various technical indicators. When you analyze PharmaCyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 55.04 | 55.04 |
| Check PharmaCyte Biotech Volatility | Backtest PharmaCyte Biotech | Information Ratio |
PharmaCyte Biotech Trading Date Momentum
| On January 26 2026 PharmaCyte Biotech was traded for 0.99 at the closing time. The top price for the day was 1.02 and the lowest listed price was 0.87 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not cause price change. The trading delta at closing time against the current closing price is 4.57% . |
| Compare PharmaCyte Biotech to competition |
Other Forecasting Options for PharmaCyte Biotech
For every potential investor in PharmaCyte, whether a beginner or expert, PharmaCyte Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. PharmaCyte Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in PharmaCyte. Basic forecasting techniques help filter out the noise by identifying PharmaCyte Biotech's price trends.PharmaCyte Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PharmaCyte Biotech stock to make a market-neutral strategy. Peer analysis of PharmaCyte Biotech could also be used in its relative valuation, which is a method of valuing PharmaCyte Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
PharmaCyte Biotech Market Strength Events
Market strength indicators help investors to evaluate how PharmaCyte Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PharmaCyte Biotech shares will generate the highest return on investment. By undertsting and applying PharmaCyte Biotech stock market strength indicators, traders can identify PharmaCyte Biotech entry and exit signals to maximize returns.
PharmaCyte Biotech Risk Indicators
The analysis of PharmaCyte Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in PharmaCyte Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pharmacyte stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.59 | |||
| Semi Deviation | 4.96 | |||
| Standard Deviation | 9.34 | |||
| Variance | 87.27 | |||
| Downside Variance | 35.92 | |||
| Semi Variance | 24.57 | |||
| Expected Short fall | (6.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for PharmaCyte Biotech
The number of cover stories for PharmaCyte Biotech depends on current market conditions and PharmaCyte Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PharmaCyte Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PharmaCyte Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
PharmaCyte Biotech Short Properties
PharmaCyte Biotech's future price predictability will typically decrease when PharmaCyte Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PharmaCyte Biotech often depends not only on the future outlook of the potential PharmaCyte Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PharmaCyte Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.3 M | |
| Cash And Short Term Investments | 15.5 M |
Check out Historical Fundamental Analysis of PharmaCyte Biotech to cross-verify your projections. For information on how to trade PharmaCyte Stock refer to our How to Trade PharmaCyte Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PharmaCyte Biotech. If investors know PharmaCyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PharmaCyte Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PharmaCyte Biotech is measured differently than its book value, which is the value of PharmaCyte that is recorded on the company's balance sheet. Investors also form their own opinion of PharmaCyte Biotech's value that differs from its market value or its book value, called intrinsic value, which is PharmaCyte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PharmaCyte Biotech's market value can be influenced by many factors that don't directly affect PharmaCyte Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PharmaCyte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if PharmaCyte Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PharmaCyte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.